Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer

NCT01872377 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped No longer recruiting patients to this study

Conditions

Pancreatic Carcinoma Non-resectable

Interventions

RADIATION: CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost

Sponsor

Ottawa Hospital Research Institute